Acyclovir delivery systems

被引:19
作者
Cortesi, Rita [1 ]
Esposito, Elisabetta [1 ]
机构
[1] Univ Ferrara, Dept Pharmaceut Sci, CoReS Techno Grp, I-44100 Ferrara, Italy
关键词
acyclovir; drug delivery; drug formulations; herpes simplex virus; microparticles; microemulsions; nanoparticles; vesicles;
D O I
10.1517/17425240802450340
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Herpes viruses (herpes simplex, varicella zoster, cytomegalovirus) are the main cause of a wide variety of human infections. Although the development of successful antiviral agents against infections caused by herpes viruses had been slow until the last decade, the production of delivery systems for acyclovir are a promising alternative. The present review summarizes the principal advances made in developing carriers for the delivery of acyclovir by different routes of administration.
引用
收藏
页码:1217 / 1230
页数:14
相关论文
共 130 条
[1]  
ABLA N, 2005, PERCUTANEOUS PENETRA, P177
[2]   Topical iontophoresis of valaciclovir hydrochloride improves cutaneous aciclovir delivery [J].
Abla, Nada ;
Naik, Aarti ;
Guy, Richard H. ;
Kalia, Yogeshvar N. .
PHARMACEUTICAL RESEARCH, 2006, 23 (08) :1842-1849
[3]   Valacyclovir [J].
Acosta, EP ;
Fletcher, CV .
ANNALS OF PHARMACOTHERAPY, 1997, 31 (02) :185-191
[4]   CHEMICAL ASPECTS OF SELECTIVE TOXICITY [J].
ALBERT, A .
NATURE, 1958, 182 (4633) :421-423
[5]   IMPROVING INTESTINAL-ABSORPTION OF WATER-INSOLUBLE COMPOUNDS - A MEMBRANE METABOLISM STRATEGY [J].
AMIDON, GL ;
LEESMAN, GD ;
ELLIOTT, RL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) :1363-1368
[6]   Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: Interactions with the neutral and cationic amino acid transporter on the corneal epithelium [J].
Anand, BS ;
Katragadda, S ;
Nashed, YE ;
Mitra, AK .
CURRENT EYE RESEARCH, 2004, 29 (2-3) :153-166
[7]   Current prodrug strategies via membrane transporters/receptors [J].
Anand, BS ;
Dey, S ;
Mitra, AK .
EXPERT OPINION ON BIOLOGICAL THERAPY, 2002, 2 (06) :607-620
[8]   Macrophages and HIV infection:: therapeutical approaches toward this strategic virus reservoir [J].
Aquaro, S ;
Caliò, R ;
Balzarini, J ;
Bellocchi, MC ;
Garaci, E ;
Perno, CF .
ANTIVIRAL RESEARCH, 2002, 55 (02) :209-225
[9]   Influence of a Niosomal Formulation on the Oral Bioavailability of Acyclovir in Rabbits [J].
Attia, Ismail A. ;
El-Gizawy, Sanaa A. ;
Fouda, Medhat A. ;
Donia, Ahmed M. .
AAPS PHARMSCITECH, 2007, 8 (04)
[10]   UTILIZATION OF PEPTIDE CARRIER SYSTEM TO IMPROVE INTESTINAL-ABSORPTION - TARGETING PROLIDASE AS A PRODRUG-CONVERTING ENZYME [J].
BAI, JPF ;
HU, M ;
SUBRAMANIAN, P ;
MOSBERG, HI ;
AMIDON, GL .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1992, 81 (02) :113-116